LGM Pharma is a Vilazodone 163521-12-8 active pharmaceutical ingredient supplier, based in the USA.
Questions? Call our customer API support number 1-(800)-881-8210.
LGM Pharma offers this active ingredient but not the finished dosage forms.Inquire about Vilazodone
|Molecular Weight:||441.524 g/mol|
|Assay/Purity:||Typically NLT 98%|
- Vilazodone, CAS 163521-12-8 is in a class of medications called selective serotonin reuptake inhibitors, or SSRIs, and is also a 5HT1A receptor partial agonist.
- Known as the brand name Viibryd, vilazodone was approved in January of 2011 to treat Major Depressive Disorder in adults.
- Titration of the vilazodone dose is suggested, beginning an initial dose of 10 mg once daily for 7 days.
- Vilazodone has a minimal on sexual function, as shown in clinical studies.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1).
Any patent infringement and resulting liability is solely at buyer risk.